On Tuesday, Medical Facilities Corp. announced that former COO Robert Horrar would become its new CEO.
“I am honoured to assume leadership of Medical Facilities during such an exciting time of change and opportunity in the industry,” Horrar said. “The company has successfully evolved to meet the ever-changing demands of the U.S. health care environment and is in an excellent position to achieve both organic and acquisitive growth. In tandem with our hospital and centre leadership and physician partners, I look forward to further building shareholder value.”
Linsdell says this announcement did not catch him off-guard.
“We had expected the appointment of a permanent CEO before the end of the year, and suspected that it would be an internal promotion of either Rob Horrar, or Chief Development Officer, Jim Rolfe, so this announcement comes as little surprise and does not alter any of our expectations or forecasts,” the analyst says. “We still expect to see acquisitions over the next few months and quarters as MFC continues to build out its network of specialty surgical hospitals, ambulatory surgical centres, and urgent care facilities. As we run through the end of the year, which is typically MFC’s strongest season, we expect the increased certainty related to a permanent CEO to resonate well with investors.”
In a research update to clients today, Linsdell maintained his “Buy” rating and one-year price target of $20.00 on Medical Facilities Corp., implying a return of 39 per cent at the time of publication.
The analyst thinks the company will generate EBITDA of $99.9-million on revenue of $388.4-million in fiscal 2017. He expects those numbers will improve to EBITDA of $116.1-million on a topline of $407.4-million the following year.
Canada’s labour market has softened sharply since the start of the year, with the unemployment rate reaching 7% in May,… [Read More]
Count RBC Capital Markets analyst Ken Herbert among the believers in MDA (MDA Stock Quote, Chart, News, Analysts, Financials TSX:MDA).… [Read More]
Roth Capital Markets analyst Suji Desilva said in a July 3 report that Netlist (Netlist Stock Quote, Chart, News, Analysts,… [Read More]
Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares… [Read More]
Haywood Capital Markets analyst Gianluca Tucci reiterated a “Buy” rating on KITS Eyecare (KITS Eyecare Stock Quote, Chart, News, Analysts,… [Read More]
Roth Capital Markets analyst Suji Desilva maintained a “Buy” rating and US$18.00 target on D-Wave Quantum (D-Wave Quantum Stock Quote,… [Read More]